Hayat Pharmaceutical Industries Past Earnings Performance
Past criteria checks 2/6
Hayat Pharmaceutical Industries has been growing earnings at an average annual rate of 0.4%, while the Pharmaceuticals industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 3.5% per year. Hayat Pharmaceutical Industries's return on equity is 8.2%, and it has net margins of 14.4%.
Key information
0.4%
Earnings growth rate
0.4%
EPS growth rate
Pharmaceuticals Industry Growth | 12.4% |
Revenue growth rate | 3.5% |
Return on equity | 8.2% |
Net Margin | 14.4% |
Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Hayat Pharmaceutical Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 15 | 2 | 6 | 1 |
31 Mar 23 | 17 | 3 | 7 | 1 |
31 Dec 22 | 17 | 4 | 6 | 1 |
30 Sep 22 | 16 | 3 | 6 | 1 |
30 Jun 22 | 15 | 3 | 6 | 1 |
31 Mar 22 | 14 | 2 | 6 | 0 |
31 Dec 21 | 17 | 4 | 6 | 0 |
30 Sep 21 | 18 | 5 | 7 | 0 |
30 Jun 21 | 18 | 4 | 7 | 0 |
31 Mar 21 | 17 | 4 | 7 | 0 |
31 Dec 20 | 17 | 4 | 7 | 0 |
30 Sep 20 | 17 | 4 | 6 | 0 |
30 Jun 20 | 17 | 4 | 7 | 0 |
31 Mar 20 | 17 | 4 | 6 | 0 |
31 Dec 19 | 16 | 3 | 6 | 0 |
30 Sep 19 | 15 | 3 | 6 | 0 |
30 Jun 19 | 14 | 3 | 5 | 0 |
31 Mar 19 | 14 | 3 | 5 | 0 |
31 Dec 18 | 14 | 3 | 5 | 0 |
30 Sep 18 | 13 | 2 | 5 | 0 |
30 Jun 18 | 13 | 3 | 5 | 0 |
31 Dec 17 | 13 | 2 | 5 | 0 |
30 Sep 17 | 13 | 3 | 5 | 0 |
30 Jun 17 | 12 | 3 | 4 | 0 |
31 Mar 17 | 11 | 2 | 4 | 0 |
31 Dec 16 | 11 | 2 | 4 | 0 |
30 Sep 16 | 10 | 3 | 3 | 0 |
30 Jun 16 | 11 | 2 | 4 | 0 |
31 Mar 16 | 11 | 2 | 4 | 0 |
31 Dec 15 | 11 | 2 | 4 | 0 |
30 Sep 15 | 11 | 2 | 4 | 0 |
30 Jun 15 | 11 | 2 | 5 | 0 |
31 Mar 15 | 11 | 2 | 5 | 0 |
31 Dec 14 | 11 | 2 | 5 | 0 |
30 Sep 14 | 10 | 2 | 4 | 0 |
30 Jun 14 | 10 | 2 | 4 | 0 |
31 Mar 14 | 9 | 2 | 4 | 0 |
31 Dec 13 | 10 | 2 | 4 | 0 |
30 Sep 13 | 10 | 2 | 5 | 0 |
30 Jun 13 | 9 | 2 | 4 | 0 |
31 Mar 13 | 8 | 2 | 4 | 0 |
Quality Earnings: HPIC has high quality earnings.
Growing Profit Margin: HPIC's current net profit margins (14.4%) are lower than last year (17.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HPIC's earnings have grown by 0.4% per year over the past 5 years.
Accelerating Growth: HPIC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: HPIC had negative earnings growth (-15.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (9.8%).
Return on Equity
High ROE: HPIC's Return on Equity (8.2%) is considered low.